281 related articles for article (PubMed ID: 24986660)
1. Design and synthesis of lactam-thiophene carboxylic acids as potent hepatitis C virus polymerase inhibitors.
Barnes-Seeman D; Boiselle C; Capacci-Daniel C; Chopra R; Hoffmaster K; Jones CT; Kato M; Lin K; Ma S; Pan G; Shu L; Wang J; Whiteman L; Xu M; Zheng R; Fu J
Bioorg Med Chem Lett; 2014 Aug; 24(16):3979-85. PubMed ID: 24986660
[TBL] [Abstract][Full Text] [Related]
2. 2-(3-Thienyl)-5,6-dihydroxypyrimidine-4-carboxylic acids as inhibitors of HCV NS5B RdRp.
Pacini B; Avolio S; Ercolani C; Koch U; Migliaccio G; Narjes F; Pacini L; Tomei L; Harper S
Bioorg Med Chem Lett; 2009 Nov; 19(21):6245-9. PubMed ID: 19800789
[TBL] [Abstract][Full Text] [Related]
3. C-6 aryl substituted 4-quinolone-3-carboxylic acids as inhibitors of hepatitis C virus.
Chen YL; Zacharias J; Vince R; Geraghty RJ; Wang Z
Bioorg Med Chem; 2012 Aug; 20(15):4790-800. PubMed ID: 22748708
[TBL] [Abstract][Full Text] [Related]
4. Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives.
Beaulieu PL; Bös M; Bousquet Y; Fazal G; Gauthier J; Gillard J; Goulet S; LaPlante S; Poupart MA; Lefebvre S; McKercher G; Pellerin C; Austel V; Kukolj G
Bioorg Med Chem Lett; 2004 Jan; 14(1):119-24. PubMed ID: 14684311
[TBL] [Abstract][Full Text] [Related]
5. Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 1: Sulfonamides.
Chan L; Das SK; Reddy TJ; Poisson C; Proulx M; Pereira O; Courchesne M; Roy C; Wang W; Siddiqui A; Yannopoulos CG; Nguyen-Ba N; Labrecque D; Bethell R; Hamel M; Courtemanche-Asselin P; L'Heureux L; David M; Nicolas O; Brunette S; Bilimoria D; Bédard J
Bioorg Med Chem Lett; 2004 Feb; 14(3):793-6. PubMed ID: 14741291
[TBL] [Abstract][Full Text] [Related]
6. N-Acetamideindolecarboxylic acid allosteric 'finger-loop' inhibitors of the hepatitis C virus NS5B polymerase: discovery and initial optimization studies.
Beaulieu PL; Jolicoeur E; Gillard J; Brochu C; Coulombe R; Dansereau N; Duan J; Garneau M; Jakalian A; Kühn P; Lagacé L; LaPlante S; McKercher G; Perrault S; Poirier M; Poupart MA; Stammers T; Thauvette L; Thavonekham B; Kukolj G
Bioorg Med Chem Lett; 2010 Feb; 20(3):857-61. PubMed ID: 20074949
[TBL] [Abstract][Full Text] [Related]
7. Preparation and biological evaluation of 1'-cyano-2'-C-methyl pyrimidine nucleosides as HCV NS5B polymerase inhibitors.
Mish MR; Cho A; Kirschberg T; Xu J; Zonte CS; Fenaux M; Park Y; Babusis D; Feng JY; Ray AS; Kim CU
Bioorg Med Chem Lett; 2014 Jul; 24(14):3092-5. PubMed ID: 24907145
[TBL] [Abstract][Full Text] [Related]
8. Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency.
Beaulieu PL; Bös M; Bousquet Y; DeRoy P; Fazal G; Gauthier J; Gillard J; Goulet S; McKercher G; Poupart MA; Valois S; Kukolj G
Bioorg Med Chem Lett; 2004 Feb; 14(4):967-71. PubMed ID: 15013003
[TBL] [Abstract][Full Text] [Related]
9. Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 2: tertiary amides.
Chan L; Pereira O; Reddy TJ; Das SK; Poisson C; Courchesne M; Proulx M; Siddiqui A; Yannopoulos CG; Nguyen-Ba N; Roy C; Nasturica D; Moinet C; Bethell R; Hamel M; L'Heureux L; David M; Nicolas O; Courtemanche-Asselin P; Brunette S; Bilimoria D; Bédard J
Bioorg Med Chem Lett; 2004 Feb; 14(3):797-800. PubMed ID: 14741292
[TBL] [Abstract][Full Text] [Related]
10. Cyclic amide bioisosterism: strategic application to the design and synthesis of HCV NS5B polymerase inhibitors.
Yang H; Hendricks RT; Arora N; Nitzan D; Yee C; Lucas MC; Yang Y; Fung A; Rajyaguru S; Harris SF; Leveque VJ; Hang JQ; Pogam SL; Reuter D; Tavares GA
Bioorg Med Chem Lett; 2010 Aug; 20(15):4614-9. PubMed ID: 20584604
[TBL] [Abstract][Full Text] [Related]
11. 5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase.
Ellis DA; Blazel JK; Tran CV; Ruebsam F; Murphy DE; Li LS; Zhao J; Zhou Y; McGuire HM; Xiang AX; Webber SE; Zhao Q; Han Q; Kissinger CR; Lardy M; Gobbi A; Showalter RE; Shah AM; Tsan M; Patel RA; LeBrun LA; Kamran R; Bartkowski DM; Nolan TG; Norris DA; Sergeeva MV; Kirkovsky L
Bioorg Med Chem Lett; 2009 Nov; 19(21):6047-52. PubMed ID: 19796938
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Novel Thiophene-Based, Thumb Pocket 2 Allosteric Inhibitors of the Hepatitis C NS5B Polymerase with Improved Potency and Physicochemical Profiles.
Court JJ; Poisson C; Ardzinski A; Bilimoria D; Chan L; Chandupatla K; Chauret N; Collier PN; Das SK; Denis F; Dorsch W; Iyer G; Lauffer D; L'Heureux L; Li P; Luisi BS; Mani N; Nanthakumar S; Nicolas O; Rao BG; Ronkin S; Selliah S; Shawgo RS; Tang Q; Waal ND; Yannopoulos CG; Green J
J Med Chem; 2016 Jul; 59(13):6293-302. PubMed ID: 27366941
[TBL] [Abstract][Full Text] [Related]
13. [Non-hydrolysable analogs of inorganic pyrophosphate as inhibitors of hepatitis C virus RNA-dependent RNA-polymerase].
Ianvarev DV; Korovina AN; Usanov NN; Kochetkov SN
Bioorg Khim; 2012; 38(2):257-62. PubMed ID: 22792731
[TBL] [Abstract][Full Text] [Related]
14. Discovery of BMS-961955, an allosteric inhibitor of the hepatitis C virus NS5B polymerase.
Zheng BZ; D'Andrea SV; Hanumegowda U; Knipe JO; Mosure K; Zhuo X; Lemm JA; Liu M; Rigat KL; Wang YK; Fang H; Poronsky C; Cutrone J; Wu DR; Arunachalam PN; Balapragalathan TJ; Arumugam A; Mathur A; Meanwell NA; Gao M; Roberts SB; Kadow JF
Bioorg Med Chem Lett; 2017 Aug; 27(15):3294-3300. PubMed ID: 28633899
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and SAR optimization of diketo acid pharmacophore for HCV NS5B polymerase inhibition.
Bhatt A; Gurukumar KR; Basu A; Patel MR; Kaushik-Basu N; Talele TT
Eur J Med Chem; 2011 Oct; 46(10):5138-45. PubMed ID: 21893371
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a novel series of potent non-nucleoside inhibitors of hepatitis C virus NS5B.
Schoenfeld RC; Bourdet DL; Brameld KA; Chin E; de Vicente J; Fung A; Harris SF; Lee EK; Le Pogam S; Leveque V; Li J; Lui AS; Najera I; Rajyaguru S; Sangi M; Steiner S; Talamas FX; Taygerly JP; Zhao J
J Med Chem; 2013 Oct; 56(20):8163-82. PubMed ID: 24069953
[TBL] [Abstract][Full Text] [Related]
17. Identification of N,N-disubstituted phenylalanines as a novel class of inhibitors of hepatitis C NS5B polymerase.
Chan L; Reddy TJ; Proulx M; Das SK; Pereira O; Wang W; Siddiqui A; Yannopoulos CG; Poisson C; Turcotte N; Drouin A; Alaoui-Ismaili MH; Bethell R; Hamel M; L'Heureux L; Bilimoria D; Nguyen-Ba N
J Med Chem; 2003 Apr; 46(8):1283-5. PubMed ID: 12672227
[TBL] [Abstract][Full Text] [Related]
18. Active site inhibitors of HCV NS5B polymerase. The development and pharmacophore of 2-thienyl-5,6-dihydroxypyrimidine-4-carboxylic acid.
Stansfield I; Avolio S; Colarusso S; Gennari N; Narjes F; Pacini B; Ponzi S; Harper S
Bioorg Med Chem Lett; 2004 Oct; 14(20):5085-8. PubMed ID: 15380204
[TBL] [Abstract][Full Text] [Related]
19. Recent advances on the synthesis of hepatitis C virus NS5B RNA-dependent RNA-polymerase inhibitors.
Zhao C; Wang Y; Ma S
Eur J Med Chem; 2015 Sep; 102():188-214. PubMed ID: 26276434
[TBL] [Abstract][Full Text] [Related]
20. Parallel synthesis of 5-cyano-6-aryl-2-thiouracil derivatives as inhibitors for hepatitis C viral NS5B RNA-dependent RNA polymerase.
Ding Y; Girardet JL; Smith KL; Larson G; Prigaro B; Wu JZ; Yao N
Bioorg Chem; 2006 Feb; 34(1):26-38. PubMed ID: 16360193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
